Risky Business Of FDA Mobile Medical Apps

Law360, New York (October 31, 2013, 5:45 PM EDT) -- The U.S. Food and Drug Administration has issued final guidance[1] on mobile medical applications, which are mobile apps that meet the definition of a device[2] and are intended to be used as an accessory to a regulated medical device or to transform a mobile platform into a regulated medical device. Mobile apps are software applications that are run through mobile platforms (e.g., smartphones, tablet computers and other handheld computing platforms) or certain web-based software applications.

The final guidance states that the FDA will apply its regulatory authority...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.